Trial of Educational Modification Sessions and Sunless Tanner AS A Method of Reducing the Incidence of Tanning Bed Use in Young Adults


About this study

This phase II four armed factorial randomized clinical trial will look at tanning bed use reduction in the setting of skin cancer directed educational sessions in young adults with frequent tanning bed use. It is hoped that the experimental treatment of education sun safety sessions and free sunless tanner samples will be successful in decreasing the mean frequency of tanning bed use.  In addition to tanning bed use reduction, this trial will also determine tanning bed use abstinence and compare the frequent application of sun screen in addition to other healthy habits among participants.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Young adults between the ages of 18 and 40 years old who have screened positive as a frequent tanning bed user on a pre-study questionnaire. 
  • Frequent tanning bed use will be defined as attending a commercial tanning bed facility at least 1 time within the previous 2 years. 

Exclusion Criteria:

Young adults will be excluded from the study if any of the following criteria are met:

  1. A personal prior history of melanoma
  2. A personal prior history of basal cell or squamous cell carcinoma
  3. Currently seeing a dermatologist with at least one visit within the last 12 months
  4. Skin condition necessitating light therapy (i.e. psoriasis)


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Jerry Brewer, M.D., M.S.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer